Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ | 19 897 | déclaré | 30 nov. 2022 | tx 8+426 000−6 103 |
| Viridian Therapeutics, Inc.\DE | 16 409 | déclaré | 03 mars 2026 | tx 10+964 109−15 595 |
| Kiniksa Pharmaceuticals International, plc | 5 855 | déclaré | 20 mars 2021 | tx 26+728 230−464 134 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 03 mars 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 9 409 | — | |
| 03 mars 2026 | TAX_WITHHOLDING | Viridian Therapeutics, Inc.\DE | 3 138 | 29.32 USD | |
| 03 mars 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 9 409 | 0.00 USD | deriv |
| 02 mars 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 35 300 | 0.00 USD | deriv |
| 02 mars 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 176 550 | 0.00 USD | deriv |
| 03 mars 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 225 814 | 0.00 USD | deriv |
| 03 mars 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 37 636 | 0.00 USD | deriv |
| 27 sept. 2024 | PURCHASE | Viridian Therapeutics, Inc.\DE | 5 000 | 23.41 USD | 1er après silence |
| 30 oct. 2023 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 474 400 | 0.00 USD | deriv |
| 30 nov. 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 3 000 | 0.94 USD | |
| 01 août 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 75 000 | 0.00 USD | deriv |
| 31 mai 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 3 000 | 0.99 USD | |
| 17 mai 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 50 000 | 0.00 USD | deriv |
| 15 févr. 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 75 000 | 0.00 USD | deriv |
| 16 sept. 2021 | SALE | Dianthus Therapeutics, Inc. /DE/ | 6 103 | 6.73 USD | |
| 14 sept. 2021 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 20 000 | 0.00 USD | |
| 14 juin 2021 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 200 000 | 0.00 USD | deriv |
| 20 mars 2021 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 5 855 | 0.00 USD | deriv |
| 20 mars 2021 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 4 287 | 0.00 USD | deriv |
| 16 mars 2021 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 8 769 | 0.00 USD | deriv |
| 16 mars 2021 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 52 611 | 0.00 USD | deriv |
| 03 févr. 2021 | SALE | Kiniksa Pharmaceuticals International, plc | 2 477 | 22.09 USD | |
| 03 févr. 2021 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 300 000 | — | |
| 03 févr. 2021 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 300 000 | 0.00 USD | deriv |
| 10 sept. 2020 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 75 000 | 0.00 USD | deriv |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 27 sept. 2024.